Oct 16, 2026 · 33 min
Peptide therapy meets personalized care and entrepreneurial risk
The Peptide Revolution with Tom and Judi Casey
The conversation connects emerging peptide treatments with the medical oversight, patient history, and business discipline needed to use them responsibly.
- 1Individualized hormone treatment may matter when standard laboratory ranges do not match a patient’s symptoms or experience.
- 2The guests stress comprehensive testing, medical history, careful dosing, and pharmacy oversight instead of unsupervised online peptide use.
- 3The Caseys link health-business growth to mentorship, accountability, employee care, patience, and thoughtful risk-taking.
Don't miss
Brandon recounts how Lyme disease and co-infections led to severe autoimmune problems before a peptide regimen helped reduce inflammation and restore his health.
The brief
Brandon Brittingham speaks with Tom and Judi Casey about peptide and hormone therapy, beginning with testosterone treatment and the limits of relying on standard laboratory ranges alone.
The Caseys argue that peptide care requires comprehensive blood work, medical history, individualized dosing, and pharmacy oversight—not casual purchases or unsupervised use online.
Tom describes using peptides after injuries from strongman, powerlifting, and corrections work, while the discussion considers reported applications involving healing, inflammation, energy, skin, hair, and cognition.
Brandon recounts severe autoimmune problems linked to Lyme disease and co-infections, describing how a peptide regimen helped reduce inflammation and restore his health.
The conversation then shifts from treatment to enterprise: Tom and Judi discuss mentorship, accountability, employee care, stewardship, freedom, and the patience required to build a medical practice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.